M J Lysaght1, B Frydel, F Gentile
1CytoTherapeutics, Inc., Providence, Rhode Island 02906.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Biohybrid implants use living cells in a hydrogel matrix to deliver therapeutic reagents. This innovative medical device technology is advancing beyond diabetes treatment to address chronic pain and neurodegenerative disorders.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: